Literature DB >> 31284923

Importance of Virus Characteristics in Respiratory Syncytial Virus-Induced Disease.

Homero San-Juan-Vergara1, Mark E Peeples2.   

Abstract

Severe lower respiratory tract infection in infants and young children is most frequently caused by respiratory syncytial virus (RSV). RSV infects the smallest airways, making breathing difficult and in some infants requiring medical support. Severity is affected by viral dose, infant age, virus genotype, and effectiveness of the innate/adaptive immune responses. Severe disease correlates with later wheezing and asthma in some children. The adaptive immune response is protective but wanes after each infection, likely due to the ability of the RSV NS1/NS2 proteins to inhibit the innate immune response. Several vaccine approaches and candidates are currently in clinical trials.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  G protein; Genotypes; Neutralizing antibody; Postfusion; Prefusion; Respiratory syncytial virus (RSV); Vaccine

Mesh:

Substances:

Year:  2019        PMID: 31284923      PMCID: PMC6879194          DOI: 10.1016/j.iac.2019.04.001

Source DB:  PubMed          Journal:  Immunol Allergy Clin North Am        ISSN: 0889-8561            Impact factor:   3.479


  58 in total

Review 1.  Immunological mechanisms of vaccination.

Authors:  Bali Pulendran; Rafi Ahmed
Journal:  Nat Immunol       Date:  2011-06       Impact factor: 25.606

2.  Respiratory syncytial virus induces phosphorylation of mTOR at ser2448 in CD8 T cells from nasal washes of infected infants.

Authors:  A P Duarte de Souza; D Nascimento de Freitas; K E Antuntes Fernandes; M D'Avila da Cunha; J L Antunes Fernandes; R Benetti Gassen; T Fazolo; L A Pinto; M Scotta; R Mattiello; P M Pitrez; C Bonorino; R T Stein
Journal:  Clin Exp Immunol       Date:  2015-11-24       Impact factor: 4.330

3.  Structure and functional dynamics characterization of the ion channel of the human respiratory syncytial virus (hRSV) small hydrophobic protein (SH) transmembrane domain by combining molecular dynamics with excited normal modes.

Authors:  Gabriela C Araujo; Ricardo H T Silva; Luis P B Scott; Alexandre S Araujo; Fatima P Souza; Ronaldo Junio de Oliveira
Journal:  J Mol Model       Date:  2016-11-05       Impact factor: 1.810

4.  Respiratory syncytial virus infection of human airway epithelial cells is polarized, specific to ciliated cells, and without obvious cytopathology.

Authors:  Liqun Zhang; Mark E Peeples; Richard C Boucher; Peter L Collins; Raymond J Pickles
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

5.  Identification of nucleolin as a cellular receptor for human respiratory syncytial virus.

Authors:  Farnoosh Tayyari; David Marchant; Theo J Moraes; Wenming Duan; Peter Mastrangelo; Richard G Hegele
Journal:  Nat Med       Date:  2011-08-14       Impact factor: 53.440

6.  Enhanced pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of interleukin-4 (IL-4) and IL-10.

Authors:  M Connors; N A Giese; A B Kulkarni; C Y Firestone; H C Morse; B R Murphy
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

7.  Human respiratory syncytial virus nonstructural protein NS2 antagonizes the activation of beta interferon transcription by interacting with RIG-I.

Authors:  Zhenhua Ling; Kim C Tran; Michael N Teng
Journal:  J Virol       Date:  2009-02-04       Impact factor: 5.103

8.  EGFR Interacts with the Fusion Protein of Respiratory Syncytial Virus Strain 2-20 and Mediates Infection and Mucin Expression.

Authors:  Michael G Currier; Sujin Lee; Christopher C Stobart; Anne L Hotard; Remi Villenave; Jia Meng; Carla D Pretto; Michael D Shields; Minh Trang Nguyen; Sean O Todd; Michael H Chi; Jason Hammonds; Stefanie A Krumm; Paul Spearman; Richard K Plemper; Kaori Sakamoto; R Stokes Peebles; Ultan F Power; Martin L Moore
Journal:  PLoS Pathog       Date:  2016-05-06       Impact factor: 6.823

9.  Caveolae provide a specialized membrane environment for respiratory syncytial virus assembly.

Authors:  Alexander Ludwig; Tra Huong Nguyen; Daniel Leong; Laxmi Iyer Ravi; Boon Huan Tan; Sara Sandin; Richard J Sugrue
Journal:  J Cell Sci       Date:  2017-02-02       Impact factor: 5.285

10.  Structural basis for recognition of the central conserved region of RSV G by neutralizing human antibodies.

Authors:  Harrison G Jones; Tina Ritschel; Gabriel Pascual; Just P J Brakenhoff; Elissa Keogh; Polina Furmanova-Hollenstein; Ellen Lanckacker; Jehangir S Wadia; Morgan S A Gilman; R Anthony Williamson; Dirk Roymans; Angélique B van 't Wout; Johannes P Langedijk; Jason S McLellan
Journal:  PLoS Pathog       Date:  2018-03-06       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.